$ABSI Absci Corporation · 美股听风

StockCharts TV发布 2026-09-18

《The Only Thing Working in This Market Right Now》

ABSI 技术面看涨（位于均线上方，RSI/MACD 为正），且基本面（AI＋合成生物）支撑其上涨。

我们来看ABSI这只股票。该股已重拾上升趋势，并重新站上其移动平均线。我们现在有正的RSI指标和正的MACD指标。这家公司结合了人工智能与合成生物学，因此它正在上涨。

We are here with ABSI stock. The stock has regained its upward trend and is back above its moving averages. We now have a positive RSI indicator and a positive MACD indicator .

This company combines artificial intelligence and synthetic biology, and therefore it is on the rise.

看原视频16:11

更早的记录

The Acquirers Podcast发布 2026-09-02

《Patience Is the Ultimate Edge in Investing | Matt Sweeney》

$ABSI看涨

持有ABSI是基于其待决的特许权诉讼；有利的审判结果支持上行空间（可能带来数倍回报），若败诉则有特许权现金流提供下行保护。

例如，Anaptist Biosciences是我持有的一只股票，他们基本上最近将他们的开发资产与特许权使用费流分离。

So like there's for example um Anaptist Biosciences is a stock I own where they you know basically re recently they separated their development assets from a royalty stream.

所以很多人因为开发资产而持有该股。那些开发资产不再存在。那些因为开发资产而持有的人，大概会卖出。然后你有一个特许权使用费流，还有围绕特许权使用费流的诉讼。

So a lot of people own the stock for development assets. Those development assets are no longer there. Um you know the people that own the owned it for the development assets presumably they sell.

Then you have a royalty stream and then there's litigation around the royalty stream.

他说在等

版税流诉讼审判的结论

看原视频54:42

更早的记录

ABSI

本窗口内的全部观点与内容